0001209191-19-051016.txt : 20190927
0001209191-19-051016.hdr.sgml : 20190927
20190927163709
ACCESSION NUMBER: 0001209191-19-051016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190926
FILED AS OF DATE: 20190927
DATE AS OF CHANGE: 20190927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Munsie Jeffrey A
CENTRAL INDEX KEY: 0001703041
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 191122523
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-26
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001703041
Munsie Jeffrey A
C/O CONCERT PHARMACEUTICALS, INC.
65 HAYDEN AVENUE, SUITE 3000N
LEXINGTON
MA
02421
0
1
0
0
Chief Legal Officer
Employee Stock Option (Right to Buy)
9.87
2019-09-26
4
A
0
100000
0.00
A
2029-09-25
Common Stock
100000
100000
D
This option vests as to 25% of the original 100,000 shares on September 23, 2020 and then the remaining unvested shares vest in twelve equal quarterly installments thereafter.
/s/ Jeffrey A. Munsie
2019-09-27